Hoopes Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

DRAPER, Utah–(BUSINESS WIRE)–Phillip C. Hoopes, Jr., M.D. and Majid Moshirfar, M.D. at Hoopes
Vision in Draper, Utah, are participating in the AcuFocus clinical
study for the IC-8 intraocular lens (IOL) designed for patients
with cataracts.

“As a clinical study site, we at Hoopes Vision are able to give our
patients access to the most cutting-edge treatment options for
cataracts,” Dr. Hoopes, Jr. said. “Today, we are excited to begin
enrolling patients in the IC-8 lens clinical study. This study
will focus on how small aperture technology extends the range of vision
compared to a traditional single-focus monofocal IOL. For the patient,
this may mean better near, intermediate and far vision.”

By the age of 65, an estimated 90% of people worldwide experience
changes to the natural crystalline lens of the eye. The lens gradually
becomes cloudy as a cataract develops, leading to blurry vision and
eventually vision loss. The only solution to a cataract is the surgical
removal of the natural lens and its replacement with an artificial lens
called an IOL. More than 25 million cataract procedures are performed
worldwide each year. The majority of patients with cataracts are treated
with a standard monofocal (single-focus) lens, which allows the patient
to have excellent far vision; however, patients remain dependent on
glasses for near and intermediate vision.

Dr. Phillip C. Hoopes, Jr. and Dr. Majid Moshirfar are part of a select
group of clinical investigators across the United States for the IC-8
lens study. The IC-8 lens is a clear monofocal lens with a
mini-ring placed in the center. The mini-ring has an opening, or
pinhole, designed to increase the range of vision by extending the focus
of light rays that enter the eye. The clinical study will determine if
the IC-8 lens in one eye, when paired with a standard monofocal
lens in the other eye, will provide near and intermediate vision in
addition to far vision for cataract patients.

Hoopes Vision is now enrolling patients that meet the study eligibility
criteria. Patients who comply with study commitments will be
compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing and able to participate in examinations and all
  follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens
clinical study, please contact Trey in the Research Department at Hoopes
Vision at (801) 988-7342 or at research@hoopesvision.com.

ABOUT US

Hoopes Vision is the premier LASIK, PRK, and cataract surgery facility
in Utah. Within their state-of-the-art facility, located in Draper,
Utah, clinical research occupies a dedicated wing where clinical trials
for new devices, procedures, drugs, and other technologies are
conducted. For more information go to www.hoopesvision.com
or call 801-988-7342.

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company
that develops and markets breakthrough technologies for the improvement
of vision. The IC-8 lens received its CE mark in 2014 and is available
in select markets across Europe and Asia. Founded in 2001, AcuFocus is
based in Irvine, Calif. For additional information about the IC-8
intraocular lens, visit www.ic8lensclinicalstudy.com
or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States)
law to investigational use.

Contacts

Shelle Murach
Cunningham & Associates
714 206-4138
smurach@gmail.com